CD8+ TEM tumour infiltration as a % of CD8+ cells was significantly higher in αPD1 monotherapy (** p < 0.01) and αPD1 + CTLA4 combination therapy (** p < 0.01) TRs compared to TNRs. This evidence concerns the gene CTLA4 and neoplasm.